Apollo Scientific

Indagoo

Targetmol

DMH2, or 2,5-dimethyl-1H-imidazole, is a chemical compound characterized by its imidazole ring structure, which is a five-membered heterocyclic compound containing two nitrogen atoms. This compound typically exhibits properties such as being a colorless to pale yellow liquid or solid, depending on its form and purity. DMH2 is known for its potential applications in various fields, including pharmaceuticals and organic synthesis, due to its ability to act as a ligand or catalyst in chemical reactions. It may also exhibit moderate solubility in polar solvents, which can influence its reactivity and interactions with other substances. Additionally, DMH2 may possess biological activity, making it of interest in medicinal chemistry. As with many chemical substances, safety data sheets should be consulted for handling and storage guidelines, as well as potential hazards associated with exposure. Overall, DMH2 represents a versatile compound with significant implications in both industrial and research settings.

DMH2

1206711-14-9: DMH2, or 2,5-dimethyl-1H-imidazole, is a chemical compound characterized by its imidazole ring structure, which is a five-membered heterocyclic compound containing two nitrogen atoms. This compound typically exhibits properties such as being a colorless to pale yellow liquid or solid, depending on its form and purity. DMH2 is known for its potential applications in various fields, including pharmaceuticals and organic synthesis, due to its ability to act as a ligand or catalyst in chemical reactions. It may also exhibit moderate solubility in polar solvents, which can influence its reactivity and interactions with other substances. Additionally, DMH2 may possess biological activity, making it of interest in medicinal chemistry. As with many chemical substances, safety data sheets should be consulted for handling and storage guidelines, as well as potential hazards associated with exposure. Overall, DMH2 represents a versatile compound with significant implications in both industrial and research settings.

4-(2-(4-(3-(Quinolin-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenoxy)ethyl)morpholine

DMH2 is a selective BMP type I receptor (ALK2/ALK3) inhibitor. DMH2 inhibits the proliferation of lung cancer cell lines and induces cell death.

CAS 1206711-14-9

DMH2

4-(2-(4-(3-(Quinolin-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenoxy)ethyl)morpholine

Ref: 54-OR1114730

4-(2-(4-(3-(Quinolin-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenoxy)ethyl)morpholine

Ref: IN-DA01E03G

DMH2

Ref: TM-T25346